Table 3 Willingness to start preventive medication
Disease risk | At risk of RA (%) | At risk of axSpA (%) | Rheumatologists (%) | At risk of RA versus at risk of axSpA | At risk of RA versus rheumatologists |
|---|---|---|---|---|---|
100% effective medication, no side effects | |||||
30% | 53 | 55 | 74 | p = 0.812 | p = 0.017 |
70% | 69 | 92 | 92 | p = 0.005 | p = 0.002 |
100% effective medication, minor side effects of immune suppression | |||||
30% | 26 | 29 | 31 | p = 0.727 | p = 0.554 |
70% | 40 | 66 | 76 | p = 0.007 | p < 0.001 |
100% effective medication, minor general side effects | |||||
30% | 40 | 47 | 88 | p = 0.433 | p < 0.001 |
Medication postpones disease development for 10 years, no side effects | |||||
70% | 61 | 66 | 57 | p = 0.604 | p = 0.652 |